- Home
- GRRR vs AUTL Comparison
GRRR vs AUTL Comparison
Compare GRRR & AUTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GRRR
- AUTL
- Stock Information
- Founded
- GRRR 2001
- AUTL 2014
- Country
- GRRR United Kingdom
- AUTL United Kingdom
- Employees
- GRRR N/A
- AUTL N/A
- Industry
- GRRR Computer Software: Prepackaged Software
- AUTL Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- GRRR Technology
- AUTL Health Care
- Exchange
- GRRR Nasdaq
- AUTL Nasdaq
- Market Cap
- GRRR 391.9M
- AUTL 431.1M
- IPO Year
- GRRR N/A
- AUTL 2018
- Fundamental
- Price
- GRRR $16.77
- AUTL $1.68
- Analyst Decision
- GRRR Buy
- AUTL Strong Buy
- Analyst Count
- GRRR 1
- AUTL 5
- Target Price
- GRRR $18.00
- AUTL $9.12
- AVG Volume (30 Days)
- GRRR 2.0M
- AUTL 3.9M
- Earning Date
- GRRR 08-14-2025
- AUTL 11-11-2025
- Dividend Yield
- GRRR N/A
- AUTL N/A
- EPS Growth
- GRRR N/A
- AUTL N/A
- EPS
- GRRR N/A
- AUTL N/A
- Revenue
- GRRR $93,325,178.00
- AUTL $29,934,000.00
- Revenue This Year
- GRRR $36.14
- AUTL $641.63
- Revenue Next Year
- GRRR $27.83
- AUTL $109.21
- P/E Ratio
- GRRR N/A
- AUTL N/A
- Revenue Growth
- GRRR 18.22
- AUTL 185.17
- 52 Week Low
- GRRR $3.71
- AUTL $1.11
- 52 Week High
- GRRR $44.15
- AUTL $5.00
- Technical
- Relative Strength Index (RSI)
- GRRR 39.54
- AUTL 54.13
- Support Level
- GRRR $18.12
- AUTL $1.58
- Resistance Level
- GRRR $18.68
- AUTL $1.80
- Average True Range (ATR)
- GRRR 1.29
- AUTL 0.11
- MACD
- GRRR -0.34
- AUTL 0.02
- Stochastic Oscillator
- GRRR 2.57
- AUTL 65.71
About GRRR Gorilla Technology Group Inc.
Gorilla Technology Group Inc is engaged in providing information, software, and data processing services. It is a provider of video intelligence, Internet of Things (IoT) security, edge AI data analytics, and operational technology (OT) security solutions and services. Its reportable segments are video IoT and security convergence and Other segments.
About AUTL Autolus Therapeutics plc
Autolus Therapeutics PLC is a biopharmaceutical company developing next-generation programmed T-cell therapies for the treatment of cancer. The company's clinical-stage pipeline comprises Obe-cel (obecabtagene autoleucel), AUTO1/22, AUTO3, AUTO5, AUTO6, AUTO7 & AUTO8.